Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  09 AM Call for Abstracts
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 1744-1748, May 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kamura, T.
Right arrow Articles by Andersen, A. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kamura, T.
Right arrow Articles by Andersen, A. H.

Development of Thermotolerance during Fractionated Hyperthermia in a Solid Tumor in Vivo1

Toshiharu Kamura2, Ole S. Nielsen3, Jens Overgaard and Anders H. Andersen

The Institute of Cancer Research, Radiumstationen, 44 Nörrebrogade [T. K., O. S. N., J. O.], and the Institute of Theoretical Statistics, University of Aarhus [A. H. A.], DK-8000 Aarhus C, Denmark

The effect of 43.5° water bath heating on a C3H mammary carcinoma inoculated into the foot of BALB/c x DBA F1 (hereafter called CD2F1 mice was investigated. A single heat treatment resulted in a linear dose-response relationship between heating time and tumor growth time (i.e., the time for tumors to reach 5 times the initial volume of the first treatment day). Recovery from hyperthermic damage, demonstrated by two-dose fractionation experiments (30 min + 60 min at 43.5°), increased with increasing fractionation interval and reached its maximum at a 16-hr interval. Preheating for 30 min at 43.5° induced thermal resistance to a second heat treatment at 43.5° (thermotolerance) which was evidenced by a decrease in the slope of the dose-response curves. This thermotolerance gradually increased with increasing interval and reached a maximum at a 16-hr interval with a thermotolerance ratio of 5.2. Subsequently, the thermotolerance gradually decayed and completely disappeared at a 120-hr interval. No detectable repair of hyperthermic damage was found in this tumor. In principle, these data confirm the observations on thermotolerance reported previously for cell cultures in vitro and for several normal tissues in vivo.

1 This work was supported by the Danish Cancer Society (Grants 24/79 and 87/79) and Ingeborg and Leo Danins Foundation for Scientific Research. Presented in part at the 7th Meeting of the Nordic Society for Radiation Research and Radiation Technology March 8 to 11, 1981, Gol, Norway.

2 This work was performed during a fellowship under the Ministry of Education in Denmark. Present address: Department of Obstetrics and Gynecology, School of Medicine, Kyushu University, Fukuoka City 812, Japan.

3 To whom requests for reprints should be addressed.

Received 6/25/81. Accepted 12/ 8/81.




This article has been cited by other articles:


Home page
Cancer Res.Home page
G. Kong, R. D. Braun, and M. W. Dewhirst
Characterization of the Effect of Hyperthermia on Nanoparticle Extravasation from Tumor Vasculature
Cancer Res., April 1, 2001; 61(7): 3027 - 3032.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.